📰 Trial Identifier News
Page 2 - Trial Identifier News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trial Identifier. Real-time updates on events, politics, business and more.
May 10, 2022
PALO ALTO, Calif., May 10, 2022 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developi...
May 4, 2022
Hollywood, Fla (PRWEB) May 04, 2022 -- Joe DiMaggio Children’s Hospital recently announced the successful treatment of a patient with atrial septal defects
March 1, 2022
CGuard Carotid Stent will now be a treatment option in the stenting plus medical therapy arm of the trial for patients
March 1, 2022
/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...
March 1, 2022
/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...
February 23, 2022
PALO ALTO, Calif., Feb. 23, 2022 /PRNewswire/ -- Kodiak Sciences Inc. today announced top-line results from its randomized, double-masked, active comparator-controlled Phase 2b/3 clinical... | February 23, 2022
February 23, 2022
/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD) today announced top-line results from its randomized, double-masked, active comparator-controlled Phase 2b/3...
February 9, 2022
/PRNewswire/ -- atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today...
February 8, 2022
/PRNewswire/ -- atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today...
February 8, 2022
/PRNewswire/ -- atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today...